Tufts Medical Center has joined TriNetX’s research network to improve its clinical trial process, further expanding the company’s reach as it looks to grow internationally and introduce new offerings in 2018.
The acquisition of Analytica Laser adds real-world effectiveness prediction and value assessment to Certara's service portfolio – as it aims to “tackle trial to real-world value translation,” says exec.
PharmaCyte’s live-cell encapsulation technology could change the way solid tumor cancers are treated, says CEO, as the biotech moves forward with CRO selection ahead of its Ph IIb clinical trial – which will is expected to cost between $15 and $17m.
The mobile health platform from Oracle Health Sciences enables clinical study teams to collect remote patient data from sensors, wearables, and apps – and promises to deliver “a new level of patient centricity.”
Pfizer will recruit patients with rare diseases and identify clinical trial sites with support from the TriNetX global health research network, which is becoming "the defacto platform" for research, says CEO.